CRC Screening, Simplified

As a provider, you know that routine screenings for colorectal cancer saves lives. You also know that, despite the clear risks associated with non-compliance, patients refuse to move forward with colonoscopies or fecal-based screening methods. That's why we’ve developed BeScreened™–CRC, a blood-based test that eliminates some of the biggest reservations patients have about screening for colorectal cancer.

For more information on non-clinical verification and clinical validation, take a look at our BeScreenedTM-CRC white paper.

 
 
iStock-902220772.jpg

 

“The best colorectal cancer screening test is the one that gets done.”

— Richard Wender, MD, Chief Cancer Control Officer, American Cancer Society

 

 

About BeScreenedTM-CRC

BeScreened™-CRC is an ELISA-based multiplex, screening test of three blood-based tumor-associated protein biomarkers; an oncoprotein called teratocarcinoma derived growth factor-1 (TDGF-1, Cripto-1); carcinoembryonic antigen (CEA), a well-established biomarker associated with CRC; and an extracellular matrix protein involved in early stage tumor stroma changes. These three proteins target immunological activities associated with CRC tumorigenesis; generation, invasion, progression, and migration.

The  assay results are processed through Beacon’s proprietary relational algorithm and evaluated against the algorithm’s healthy patient-state status criteria. Patients that fall within the acceptance criteria are reported as negative for the likely presence of CRC with a recommendation to stay compliant with their individual healthcare well-checks and screening needs. Patients calculated as outliers to that same criteria are reported as positive with an elevated-risk of CRC’s presence with a recommendation to follow-up with their physician to schedule a screening colonoscopy.  

 
 

A Screening Method that Saves Lives

BeScreened™–CRC is the solution to CRC screening noncompliance and was designed specifically for for this reason. It’s an easy, accurate and affordable blood-based test for CRC screening that can help increase screening compliance in the population of individuals who have been unwilling or unable to be screened using fecal-based testing or invasive imaging procedures, such as colonoscopies. In providing these individuals with another alternative test that is much easier to adopt and more convenient, we can help save more lives and assist in reducing the staggering costs associated with later stage colorectal cancer (CRC) treatment and care by increasing CRC screening compliance using BeScreened-CRC.

 
 
Doctor-Patient_Edit-Beacon.jpg

Ordering BeScreenedTM-CRC

Our test is recognized by the FDA and Centers for Medicare and Medicaid Services as a   CLIA laboratory developed test. As such, it is only available through Beacon Biomedical Inc.'s CLIA accredited laboratory (ID 03D2122615). Practitioners interested in providing BeScreened™–CRC to your screening non-compliant patients, please fill out the form or email Beacon for more details and to check on its availability in your area.  

Ease & Convenience

To provide additional ease and convenience for both practitioners and patients alike, Beacon has contracted with Sonora Quest Laboratories (SQL) to provide for sample collection and processing across the entire state of Arizona through their network of patient service centers and physician based  in-office phlebotomists.  Patients and doctors can download a BeScreened Test Requisition Form Test and take it to any SQL Patient Service Centers (PSC) to get their blood drawn.  Click here for a list of SQL PSCs near you. SQL processes the samples and then they are delivered directly to Beacon for testing and reporting. 

Contact Us

Name *
Name